Studies by Nicol et al. [10] and Kocijan et al. [11] showed that patients with OI had lower serum sclerostin levels than age- and sex-matched controls (sample sizes: n = 66 and 27, respectively). This evidence concerns the gene SOST and osteogenesis imperfecta.